May 12 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 67.70 46.09 55.30 27.74
(+46.9 pct) (+33.3 pct) (-18.3 pct) (-12.1 pct)
Operating 28.90 13.95 15.00 8.64
(+107.1 pct) (+122.4 pct) (-48.1 pct) (-38.7 pct)
Recurring 28.46 14.16 15.10 8.73
(+101.0 pct) (+123.1 pct) (-46.9 pct) (-38.7 pct)
Net
Net 19.85 9.55 10.60 6.35
(+107.9 pct) (+149.9 pct) (-46.6 pct) (-36.5 pct)
EPS 164.84 yen 79.29 yen 88.03 yen 52.77 yen
Ann Div 33.00 yen 16.00 yen 33.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 33.00 yen 16.00 yen 33.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T